Interventions to decrease HIV infectiousness in Uganda
Interventions to decrease HIV infectiousness in Uganda
批准号:
8044884
负责人:
CONNIE L CELUM
金额:
$390.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-30 至 2015-08-31
关键词:
AIDS preventionAfricaAreaAttitudeBehavioralCaringClinicalClinical ServicesCommunitiesCosts and BenefitsCounselingCouplesDiagnosticDisclosureEpidemicEpidemiologyFamilyFrequenciesFundingGuidelinesHIVHome environmentHouseholdHuman immunodeficiency virus testIncidenceInfectionInterventionKnowledgeLearningMalariaMeasuresMethodsModelingPersonsPlasmaPopulationPrevalencePreventionPrevention GuidelinesPrevention programPreventivePreventive InterventionProbability SamplesResearchRiskRisk BehaviorsRisk ReductionServicesSex BehaviorStigmataSurveysTarget PopulationsTestingTriageUgandaUnited States National Institutes of HealthViral Load resultVisitantiretroviral therapybasebehavior changecondomscostdesignevidence basefollow-upglobal healthmennovelpoint of careprogramspublic health relevanceresponsescale upsocial stigmasuccesstransmission processuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application, Interventions to decrease HIV infectiousness in Uganda, responds to the NIH Director's Opportunity for Research (RC-4) within the Global Health theme. Novel, cost-effective strategies are needed to efficiently deliver proven HIV prevention and treatment services in Africa to have a substantial impact on population HIV incidence. We posit that HIV transmission in a community can be reduced through targeted, population-level delivery of HIV prevention and care services to HIV+ persons, through increasing knowledge of HIV+ status with associated behavior change and reducing HIV infectiousness through initiation of antiretroviral therapy (ART), and prevention and treatment of co-infections such as malaria. Home-based HIV counseling and testing programs, HBCT, have achieved large scale knowledge of HIV serostatus. We will build on the HBCT platform ("HBCT-plus") with targeted diagnostic, preventive, and treatment services for HIV+ persons and behavioral counseling to reduce HIV infectiousness, which will augment our Methods of Prevention Program Project (MP-3) research in Uganda. We will implement HBCT-plus in 5000 households in a high HIV prevalence area in Uganda with point-of-care (POC) CD4 testing to triage HIV+ persons to ART following Uganda guidelines and prevention and treatment of co-infections for all HIV+ persons. We will deliver prevention-for-positives risk-reduction counseling and discordant couples counseling to reduce risk behaviors. We will conduct quarterly follow-up visits for one year to optimize uptake of clinical interventions and to assess risk behaviors and stigma. Measures of success of HBCT-plus will be impact on: 1) community viral load (average HIV plasma viral load in the community over 12 months), a marker of population-level HIV infectiousness, and 2) HIV transmission potential, a composite measure of viral load and sexual behavior among HIV+ persons with HIV- or unknown serostatus partners, who have the greatest impact on HIV spread. Specific Aims: 1) Demonstrate feasibility of HBCT-plus, with HIV testing, POC CD4 testing to triage HIV+ persons to care, and prevention-for-positives and discordant couples counseling, delivered to 5000 households in Uganda in one year, based on >90% uptake of testing and >80% linkage to care among HIV+ persons. 2) Measure the impact of HBCT-plus on HIV transmission risk in the community through assessment of community viral load and HIV transmission potential before and after HBCT- plus. 3) Measure disclosure to partners and family, HIV testing of partners, condom use, sexual frequency, and number of partners before and after positive prevention counseling for newly-identified HIV+ persons through HBCT-plus. 4) Evaluate the effect of HBCT-plus on community risk behaviors, attitudes about HIV testing, and stigma through a probability sample survey in the community. 5) Determine the incremental costs of HBCT and additional components in HBCT-plus for facilitated HIV care and counseling, and estimate the cost-benefit of community viral load reduction.
PUBLIC HEALTH RELEVANCE: HBCT-plus is a home-based HIV testing program in Uganda to increase knowledge of HIV+ status with associated behavior change, and reduce HIV infectiousness through effective linkages to antiretroviral therapy and treatment of co-infections, and assessed by reduction in community viral load and transmission potential.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men
-
批准号:10376318
-
项目类别:
-
资助金额:$258.67万
-
财政年份:2019
-
负责人:CONNIE L CELUM
-
依托单位:
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men
-
批准号:10599168
-
项目类别:
-
资助金额:$141.24万
-
财政年份:2019
-
负责人:CONNIE L CELUM
-
依托单位:
Evaluation of doxycycline post-exposure prophylaxis to reduce sexually transmitted infections in PrEP users and HIV-infected men who have sex with men
-
批准号:9914211
-
项目类别:
-
资助金额:$146.43万
-
财政年份:2019
-
负责人:CONNIE L CELUM
-
依托单位:
PrEP for Young South African Women: Evaluating Uptake by Risk Screening or a Decision Support Tool and Scaled Adherence Support Using a SMART Design
-
批准号:9404078
-
项目类别:
-
资助金额:$70.04万
-
财政年份:2017
-
负责人:CONNIE L CELUM
-
依托单位:
HIV self-testing and PrEP to increase testing and prevention uptake among male partners and improve postpartum ART use in PMTCT B+ programs in Uganda
-
批准号:9895861
-
项目类别:
-
资助金额:$65.52万
-
财政年份:2017
-
负责人:CONNIE L CELUM
-
依托单位:
PrEP for Young South African Women: Evaluating Uptake by Risk Screening or a Decision Support Tool and Scaled Adherence Support Using a SMART Design
-
批准号:10175041
-
项目类别:
-
资助金额:$58.42万
-
财政年份:2017
-
负责人:CONNIE L CELUM
-
依托单位:
Interventions to decrease HIV infectiousness in Uganda
-
批准号:8722105
-
项目类别:
-
资助金额:$51.37万
-
财政年份:2013
-
负责人:CONNIE L CELUM
-
依托单位:
Interventions to decrease HIV infectiousness in Uganda
-
批准号:8447165
-
项目类别:
-
资助金额:$115.92万
-
财政年份:2012
-
负责人:CONNIE L CELUM
-
依托单位:
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx
-
批准号:8077722
-
项目类别:
-
资助金额:$51.17万
-
财政年份:2010
-
负责人:CONNIE L CELUM
-
依托单位:
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx
-
批准号:8130323
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2010
-
负责人:CONNIE L CELUM
-
依托单位:
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx
-
批准号:7680593
-
项目类别:
-
资助金额:$92.42万
-
财政年份:2009
-
负责人:CONNIE L CELUM
-
依托单位:
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx
-
批准号:8048034
-
项目类别:
-
资助金额:$77.2万
-
财政年份:2009
-
负责人:CONNIE L CELUM
-
依托单位:
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx
-
批准号:8242878
-
项目类别:
-
资助金额:$75.7万
-
财政年份:2009
-
负责人:CONNIE L CELUM
-
依托单位:
Multi-component, Targeted HIV Prevention for sub-Saharan Africa: PreventionRx
-
批准号:7807119
-
项目类别:
-
资助金额:$84.5万
-
财政年份:2009
-
负责人:CONNIE L CELUM
-
依托单位:
Clinical Research
-
批准号:7479024
-
项目类别:
-
资助金额:$19.6万
-
财政年份:2008
-
负责人:CONNIE L CELUM
-
依托单位:
Core-Clinical Research
-
批准号:6896686
-
项目类别:
-
资助金额:$11.64万
-
财政年份:2004
-
负责人:CONNIE L CELUM
-
依托单位:
Acylovir to prevent HIV acquisition in HSV-2+persons
-
批准号:6607162
-
项目类别:
-
资助金额:$248.18万
-
财政年份:2002
-
负责人:CONNIE L CELUM
-
依托单位:
Acyclovir to Prevent HIV Acquisition in HSV-2+ Persons
-
批准号:7005128
-
项目类别:
-
资助金额:$436.38万
-
财政年份:2002
-
负责人:CONNIE L CELUM
-
依托单位:
Acylovir to prevent HIV acquisition in HSV-2+persons
-
批准号:6496544
-
项目类别:
-
资助金额:$257.19万
-
财政年份:2002
-
负责人:CONNIE L CELUM
-
依托单位:
Acyclovir to Prevent HIV Acquisition in HSV-2+ Persons
-
批准号:7117844
-
项目类别:
-
资助金额:$483.87万
-
财政年份:2002
-
负责人:CONNIE L CELUM
-
依托单位:
海外基金